Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.

@article{Wang2010PromisingRV,
  title={Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.},
  author={Chuanlin F. Wang and Xiaowei Zhang and Qingkun Song and Kun Tang},
  journal={Clinical and vaccine immunology : CVI},
  year={2010},
  volume={17 4},
  pages={
          688-90
        }
}
We evaluated the immunogenicity, safety, and antibody persistence of a Vero cell rabies vaccine manufactured in China, compared with those of Verorab. Adequate titers of antibody were observed for the two vaccines. ChengDa rabies vaccine could be a promising alternative vaccine for many developing countries which cannot afford expensive rabies vaccines. 
BETA

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Challenges and needs for China to eliminate rabies

  • Infectious diseases of poverty
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND